Evidence-Based Screening, Diagnosis and Management of Fetal Growth Restriction: Challenges and Confusions

作     者：Luming Sun Dick Oepkes Luming Sun;Dick Oepkes

作者机构：Shanghai Key Laboratory of Maternal Fetal MedicineDepartment of Fetal Medicine&Prenatal Diagnosis CenterShanghai First Maternity and Infant HospitalSchool of MedicineTongji UniversityShanghai 201204China Division of Fetal MedicineDepartment of ObstetricsLeiden University Medical CenterLeiden 2333ZAThe Netherlands 

出 版 物：《Maternal-Fetal Medicine》 (母胎医学杂志（英文）)

年 卷 期：2022年第4卷第3期

页      面：159-161页

学科分类：1002[医学-临床医学] 100211[医学-妇产科学] 10[医学] 

主　　题：fetus prevention diagnosis 

摘      要：Fetal growth restriction(FGR)describes a pathological condition in which the fetus fails to fulfill its growth potential.FGR is associated with higher perinatal mortality and morbidity rates as well as a variety of long-term adverse outcomes.1–4 Unfortunately,consensus is still lacking regarding the definition and diagnostic criteria of FGR,despite the recent publication of guidelines from the American College of Obstetricians and Gynecologists Committee,5 International Society of Ultrasound in Obstetrics and Gynecology,6 Society for Maternal-Fetal Medicine,7 and the International Federation of Gynecology and Obstetrics.8 Further well-designed and prospective clinical studies are needed to fill in knowledge gaps in the areas of screening,prevention,surveillance,diagnosis,and clinical management for FGR fetuses.In this issue,we introduce a Chinese expert consensus on FGR(Matern Fetal Med 2022;4(3):162-168)based on three-round Delphi procedures among multidisciplinary experts and organized by the Society of Chinese Perinatal Medicine,and five reviews related to several hot topics of FGR。